Ousset, P.-J.
Centre Hospitalier Universitaire de Toulouse
9 papers on CoChatORCID 0000-0002-5854-5519
Most cited papers
- Verified
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype
Vermunt, L., Sikkes, S. A. M., van den Hout, A., Handels, R., Bos, I., van der Flier, W. M., Kern, S., Ousset, P., Maruff, P., Skoog, I., et al. (2019) · Alzheimer's & Dementia
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 570
- Verified
EHT0202 in Alzheimers Disease: A 3-Month, Randomized, Placebo- Controlled, Double-Blind Study
Vellas, B., Sol, O., J. Snyder, P., Ousset, P.-J., Haddad, R., Maurin, M., Lemarie, J.-C., Desire, L., & P. Pando, M. (2011) · Current Alzheimer Research
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 133
- Verified
The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint
Jönsson, L., Wimo, A., Handels, R., Johansson, G., Boada, M., Engelborghs, S., Frölich, L., Jessen, F., Kehoe, P. G., Kramberger, M., et al. (2023) · The Lancet Regional Health - Europe
Pharmaceutical Economics and PolicyAlzheimer's disease research and treatments
Cited by 129
- Verified
Long-term progression of Alzheimer's disease in patients under antidementia drugs
Gillette‐Guyonnet, S., Andrieu, S., Nourhashemi, F., Gardette, V., Coley, N., Cantet, C., Gauthier, S., Ousset, P., Vellas, B., & REAL.FR study group (2011) · Alzheimer's & Dementia
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 64
- Verified
Progression of Alzheimer disease in Europe: data from the European ICTUS study
Vellas, B., Hausner, L., Frolich, L., Cantet, C., Gardette, V., Reynish, E., Gillette, S., Aguera-Morales, E., Auriacombe, S., Boada, M., et al. (2012) · Current Alzheimer Research
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 50
- Verified
Outcome of Alzheimer's disease: potential impact of cholinesterase inhibitors
Gillette-Guyonnet, S., Andrieu, S., Cortes, F., Nourhashemi, F., Cantet, C., Ousset, P.-J., Reynish, E., Grandjean, H., & Vellas, B. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences
Dementia and Cognitive Impairment ResearchCholinesterase and Neurodegenerative Diseases
Cited by 41
- Verified
Re-aligning scientific and lay narratives of Alzheimer's disease
Frisoni, G. B., Ritchie, C., Carrera, E., Nilsson, P., Ousset, P.-J., Molinuevo, J. L., Dubois, B., Scheltens, P., & Minoshima, S. (2019) · The Lancet Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 39
- Verified
A Longitudinal Study of Transitions Between Informal and Formal Care in Alzheimer Disease Using Multistate Models in the European ICTUS Cohort
Coley, N., Gallini, A., Garès, V., Gardette, V., Andrieu, S., Vellas, B., Reynish, E., Ousset, P. J., Andrieu, S., Burns, A., et al. (2015) · Journal of the American Medical Directors Association
Dementia and Cognitive Impairment ResearchGeriatric Care and Nursing Homes
Cited by 20
- Verified
Low circulating adropin concentrations predict increased risk of cognitive decline in community-dwelling older adults
Aggarwal, G., Morley, J. E., Vellas, B., Nguyen, A. D., Butler, A. A., for the MAPT/DSA Group, Guyonnet, S., Carrié, I., Brigitte, L., Faisant, C., et al. (2023) · GeroScience
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 13
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free